Five thousand units of heparin is most commonly 1 mL, drawn from a vial concentrated at 5,000 units per mL. That said, heparin is manufactured in several concentrations, so 5,000 units could just as easily be 0.5 mL, 0.25 mL, or even 5 mL depending on which vial is in hand. The concentration printed on the vial label is the only way to know for certain, and getting this wrong has caused fatal medication errors.
Why the Volume Varies
Heparin is sold in vials and prefilled syringes at a range of concentrations. The ones you are most likely to encounter in a hospital setting include 1,000 units/mL, 5,000 units/mL, 10,000 units/mL, and 20,000 units/mL. To get 5,000 units from each of those, you would draw up very different volumes:
- 1,000 units/mL: 5 mL
- 5,000 units/mL: 1 mL
- 10,000 units/mL: 0.5 mL
- 20,000 units/mL: 0.25 mL
The 5,000 units/mL single-dose vial is by far the most commonly stocked for subcutaneous prophylactic injections, which is why “1 mL” is the answer most nurses and pharmacists give reflexively. But multi-dose vials at higher concentrations are used routinely for intravenous drips, where a pharmacy may mix thousands of units into a bag of saline. When someone pulls heparin from one of those vials for a different purpose, the math changes fast.
Why Heparin Uses “Units” Instead of Milligrams
Most drugs are dosed in milligrams, so heparin’s unit system can feel odd. The reason goes back to how heparin was originally extracted. Early researchers isolated crude heparin powder from animal tissue, weighed it, and called the result milligrams. After the drug went commercial, one milligram was assigned a value of 100 biological activity units, essentially converting a weight measurement into a potency measurement.1JAMA Surgery. The Heparin Unit: A Source of Medical Misunderstanding The problem is that heparin extracted from animal tissue is not a single pure molecule. It is a mixture of sugar chains of varying lengths and sulfation patterns, so two batches weighing the same number of milligrams can have different anticoagulant punch.2PubMed Central. Enzymatic synthesis of glycosaminoglycan heparin Units, calibrated against a reference standard, give a more reliable measure of what the drug will actually do inside your body.
What a 5,000-Unit Dose Is Typically Used For
If you have been prescribed or administered 5,000 units of heparin, the most likely reason is prevention of blood clots while you are hospitalized. This is called venous thromboembolism (VTE) prophylaxis. The standard regimen is 5,000 units injected subcutaneously, meaning just under the skin of the abdomen or upper arm, either two or three times a day. It is one of the most common medication orders in hospital medicine.
In critically ill patients, researchers have compared twice-daily and three-times-daily prophylactic heparin and found little difference. One large study of ICU patients reported new blood clots in about 6% of patients regardless of whether they received heparin twice or three times daily, with no significant differences in bleeding or mortality between the two schedules.3PubMed. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient The choice between the two schedules often comes down to institutional preference and individual patient risk.
When heparin is used therapeutically rather than preventively, meaning to treat an existing clot or to anticoagulate during surgery, the doses climb much higher, often tens of thousands of units delivered intravenously. The 5,000-unit subcutaneous injection is a comparatively low dose designed to take the edge off clotting risk without fully thinning the blood.
Concentration Mix-Ups and Heparin Safety
Heparin consistently ranks among the most dangerous medications in hospital safety reports, and the main reason is its many available concentrations. A vial of 10,000 units/mL looks very similar to one of 1,000 units/mL. Grabbing the wrong vial and drawing up the same volume gives the patient ten times the intended dose, or one-tenth of it. Both outcomes are dangerous: too much heparin can cause life-threatening bleeding, while too little leaves the patient unprotected against clots.
This problem is especially acute with heparin flush solutions, which are used at very low concentrations (often 10 or 100 units/mL) to keep intravenous lines from clogging. Mix-ups between therapeutic heparin vials and flush vials have caused serious harm, particularly in newborns, where even small absolute errors translate to massive relative overdoses. Hospitals have responded by color-coding labels, using prefilled syringes, limiting the concentrations stocked on nursing units, and requiring barcode scanning before administration.
If you are ever in a position to administer heparin to yourself at home, as some patients on subcutaneous prophylaxis are, always check the concentration on the vial label, calculate the volume, and confirm the math before injecting. The formula is straightforward: divide the prescribed units by the concentration on the vial. For 5,000 units from a 5,000 units/mL vial, that is 5,000 ÷ 5,000 = 1 mL.
How Hospitals Know the Heparin Is Working
At the prophylactic 5,000-unit dose, routine lab monitoring is not usually needed. The dose is low enough that it rarely overshoots into dangerous territory. But when heparin is used at full therapeutic doses intravenously, hospitals monitor its effect with blood tests, most often the activated partial thromboplastin time (aPTT) or a direct anti-factor Xa assay.
The two tests do not always agree. One study found a discordance rate of about 49% between aPTT and anti-Xa results in the same patients, meaning nearly half the time the tests gave conflicting signals about whether the heparin dose was in range.4PubMed Central. Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms Patients monitored with anti-Xa reached a therapeutic level faster and needed fewer dose adjustments. A systematic review found no meaningful difference in bleeding or clotting outcomes between the two monitoring approaches.5Thrombosis Research. Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis
Part of the discordance comes from the aPTT test itself being highly sensitive to which reagent and analyzer a lab uses. Research has shown that the “therapeutic range” for aPTT can shift substantially depending on the specific combination of lab equipment, leading to disagreements about whether a patient is under-anticoagulated, on target, or over-anticoagulated.6Journal of Thrombosis and Haemostasis. APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti‐Xa reagent used for correlation This is a behind-the-scenes detail that patients rarely hear about, but it is one reason why heparin dosing in hospitals can feel like an art as much as a science.
Dosing Considerations in Larger Patients
A flat dose of 5,000 units makes no adjustment for body weight, which has led to reasonable questions about whether it is enough for people with obesity. The evidence here is somewhat reassuring but not entirely settled. One observational study of over 5,000 hospitalized patients found that VTE rates in obese patients receiving standard-dose heparin prophylaxis were comparably low to those in non-obese patients, even among those with a body mass index above 40.7Thrombosis Research. Heparin dosing for venous thromboembolism prophylaxis in obese hospitalized patients: An observational study
However, other research tells a more nuanced story. A study of ICU patients found that while morbid obesity did not increase VTE risk overall in patients receiving standard-dose heparin, there was a strong linear relationship between increasing BMI and rising VTE incidence.8PubMed. Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients Some institutions have experimented with higher prophylactic doses (such as 7,500 units two or three times daily) for patients above certain weight thresholds. One study examining this approach found that higher-dose heparin did not cause more bleeding but also did not clearly reduce clot rates compared to standard dosing.9PubMed Central. Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients The ideal prophylactic dose for patients with obesity remains an open question, and many hospitals still default to 5,000 units.
Heparin-Induced Thrombocytopenia
One of the more paradoxical risks of heparin, even at low prophylactic doses, is a condition called heparin-induced thrombocytopenia (HIT). Instead of simply thinning the blood, heparin in some patients triggers an immune reaction where the body produces antibodies against a complex of heparin and a protein on platelets. Those antibodies then activate platelets and clotting cells, actually increasing the risk of dangerous blood clots while simultaneously dropping the platelet count.10PubMed Central. Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
HIT typically develops five to ten days after heparin exposure, and it can occur with any dose and any formulation, including the low-dose subcutaneous injections used for prophylaxis. The diagnosis is made by watching for a sudden drop in platelet count and confirming with specialized antibody tests. If HIT is suspected, all heparin must be stopped immediately, including heparin flushes, and a non-heparin anticoagulant is substituted. This is one of the reasons hospitals monitor platelet counts in patients receiving heparin for more than a few days.
Reversing Heparin With Protamine
One practical advantage of unfractionated heparin over many newer anticoagulants is that it can be reversed quickly. The antidote is protamine sulfate, a positively charged protein derived from fish sperm that binds tightly to the negatively charged heparin molecule and neutralizes its anticoagulant effect. Protamine works by pulling heparin away from the clotting protein it is bound to, forming an inactive heparin-protamine complex.11PubMed Central. Protamine and Heparin Interactions: A Narrative Review
The typical dosing rule is 1 mg of protamine for every 100 units of heparin that need to be neutralized, adjusted downward depending on how long ago the heparin was given, since the body clears heparin relatively quickly on its own. Research into synthetic protamine-like molecules has shown that the reversal ability scales with the electrical charge of the peptide: more positively charged molecules neutralize heparin more effectively, though they also carry greater risk of side effects like drops in blood pressure.12Journal of Vascular Surgery. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal This reversibility is part of why unfractionated heparin remains the preferred anticoagulant during open heart surgery and other high-bleeding-risk procedures, where the surgical team needs the ability to switch clotting back on within minutes.
How Unfractionated Heparin Compares to Low-Molecular-Weight Heparins
If you have heard of drugs like enoxaparin (Lovenox), dalteparin, or tinzaparin, those are low-molecular-weight heparins (LMWHs). They are derived from unfractionated heparin but processed into shorter sugar chains that behave more predictably in the body.13PubMed Central. Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange LMWHs are dosed in milligrams rather than units (though they also have unit equivalents), are typically given once or twice daily, and do not usually require lab monitoring. For many patients, they have replaced unfractionated heparin for both prophylaxis and treatment of blood clots.
So why does anyone still use old-fashioned unfractionated heparin? A few reasons. It can be given intravenously for rapid onset and precise dose control, which matters in unstable patients. It is cleared faster from the body, making it easier to pause before surgery or a procedure. It is fully reversible with protamine, as described above. And it is safer in patients with severe kidney disease, since LMWHs are cleared by the kidneys and can accumulate to dangerous levels when kidney function is poor. Unfractionated heparin is metabolized through a different pathway and does not depend on kidney clearance to the same degree. For patients in the ICU, research has also shown that the route of administration matters: intravenous delivery of even low-molecular-weight heparin produces a significantly higher peak anti-clotting effect compared to subcutaneous injection, likely because critically ill patients absorb drugs through the skin and fat tissue less reliably.14PubMed. Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: A randomized controlled trial
Pediatric Dosing Is a Different World
Children are not small adults when it comes to heparin. In pediatric patients, especially infants and small children, heparin requirements per kilogram of body weight tend to be higher than in adults, and the variability between individual children is much wider. Research on pediatric heart surgery has shown that as patient weight decreases, the heparin dose needed per kilogram increases, and a fixed-dose protocol becomes increasingly inadequate.15Journal of Extra-Corporeal Technology. Heparin Dose Response in Pediatric Cardiopulmonary Bypass Children require individualized dosing based on their specific response, often guided by point-of-care testing during surgery.
A less obvious but very practical concern in neonates and toddlers is the physical act of drawing up tiny doses. When a baby needs a fraction of a milliliter, the dead space inside a standard syringe and needle, the small volume that stays trapped in the hub after injection, can represent a meaningful percentage of the dose. Clinicians working with very small patients are advised to use insulin syringes designed to minimize dead space or to dilute the drug before drawing it up.16Taylor & Francis Online (Pediatric Hematology and Oncology). A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns This is not a concern with a standard adult 5,000-unit dose, but it illustrates how a drug that seems straightforward at one scale becomes treacherous at another.
Where Heparin Comes From
Nearly all heparin used clinically is extracted from animal intestinal tissue, predominantly from pigs. Porcine intestinal mucosa is the standard source worldwide, and the resulting heparin has a fairly consistent chemical profile dominated by heavily sulfated sugar chains.17PubMed. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs? Bovine (cow-derived) heparin was once common but fell out of favor over concerns about transmissible animal diseases. It has been making a quiet comeback in some countries as a way to diversify the supply chain. However, the two are not interchangeable: bovine heparin has a different sulfation pattern, which affects its potency and biological behavior. Unit-for-unit equivalence between porcine and bovine heparin cannot be assumed without careful standardization.
The dependence on a single animal source concentrated in a few countries creates supply chain vulnerability. A contamination crisis in 2007–2008, in which an adulterant was introduced into Chinese-sourced heparin raw material, caused serious allergic reactions and deaths worldwide. That event spurred tighter regulatory oversight and renewed interest in synthetic or semi-synthetic alternatives, though commercially viable synthetic heparin remains elusive for now.